Company page
Immuneoncia Therapeutics Inc.
Immuneoncia Therapeutics Inc. is a public company traded under the ticker 424870 in the Korean market. The company has a market capitalization of approximately 401.5 million. Immuneoncia focuses on developing innovative therapeutic solutions in the biotechnology sector.
- Ticker
- 424870
- Market cap
- $401.5M
- Sector
- Health Technology
- Industry
- Biotechnology